To investigate whether USP22 is involved in HCC chemoresistance, the clinical data and tissues of 52 HCC patients who received TACE treatment after curative resection between 2009 and 2012 at the Second Hospital of Dalian Medical University were collected. This evidence concerns the gene USP22 and hepatocellular carcinoma.